Trial Profile
Safety and efficacy of eslicarbazepine combined with polytherapy acetate in patients with refractory epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 25 Feb 2016 New trial record